Clinical trial
Neurofunctional Characterization of Inhibitory Control in Bipolar Disorder and Major Depressive Disorder
NCT07503275 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurofunctional Characterization of Inhibitory Control in Bipolar Disorder and Major Depressive Disorder
- Lead sponsor
- CHU de Reims
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.